Results 171 to 180 of about 114,887 (311)

Human papillomavirus infections among women with cervical lesions and cervical cancer in Yueyang, China: a cross-sectional study of 3674 women from 2019 to 2022. [PDF]

Virol J, 2023
Zeng M, Zhang X, He L, Liu X, Liu H, Deng R, Qiu B, Liu F, Xiao H, Li Q, Li W, Liu C, Ge Y.   +12 more
europepmc   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

British Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu, Kaibin Dai, Zhensheng Lin, Mingfang Ye, Minfeng Chen, Xiaobo Li, Dongmei Zhang   +6 more
wiley   +1 more source

Prevalence and genotype distribution of high-risk human papillomavirus infections among women in selected communities in the Philippines: Results of the defeat HPV study. [PDF]

J Virus Erad
Tantengco OAG, Tabios IKB, Francisco AG, Velayo CL, Lintao RCV, Climacosa FMM, Dalmacio LMM, Cando LFT, Perias GAS, Acebes RAN, de Paz-Silava SLM.   +10 more
europepmc   +1 more source

Risk of primary Sjogren's Syndrome following human papillomavirus infections: a nationwide population-based cohort study. [PDF]

Front Immunol, 2022
Chen HH, Ma KS, Dong C, Chang WJ, Gao KR, Perng WT, Huang JY, Wei JC.   +7 more
europepmc   +1 more source

Papillomavirus infections

, 2010
Sten H Vermund, Madhav P Bhatta, Vikrant V Sahasrabuddhe   +2 more
openaire   +1 more source

Cervical Small Cell Neuroendocrine Carcinoma Initially Detected on Cytology: Diagnostic Pitfalls and Clues

Cytopathology, EarlyView.
This case describes the initial detection of cervical small cell neuroendocrine carcinoma on conventional endometrial and cervicovaginal liquid‐based cytology. Given its rarity and high aggressiveness, early recognition and rapid, intensive treatment are crucial for improving patient outcomes.
Yesul Jeong
wiley   +1 more source

Multiple high-risk human papillomavirus infections exacerbate cervical lesion risk: epidemiological evidence from suining, Sichuan. [PDF]

Virol J
Jing Y, Chen J, Lin F, Huang X, Liu Y, Zhao M, Ye C, Zhao L, Liu X, Yang J.   +9 more
europepmc   +1 more source

AHCC^® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections. [PDF]

Front Oncol, 2022
Smith JA, Gaikwad AA, Mathew L, Rech B, Faro JP, Lucci JA, Bai Y, Olsen RJ, Byrd TT.   +8 more
europepmc   +1 more source

HPV42 – a human papillomavirus classified as a low‐risk type with oncogenic potential

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Human papillomavirus (HPV) type 42 is a rare HPV type currently classified as “low‐risk” and belongs to the alpha genus. It has primarily been detected in benign vulvar papillomas and is predominantly associated with benign lesions such as anogenital warts.
Sven Niklas Burmann, Ulrike Wieland, Steffi Silling, Frank Oellig, David Chromy, Julia Hyun, Thilo Gambichler, Alexander Kreuter   +7 more
wiley   +1 more source

Targeting papillomavirus infections: high-throughput screening reveals an effective inhibitor of cutaneous β-HPV types. [PDF]

J Virol
Ibragimov R, Babok S, Lototskaja-Perepelenko E, Ivanova L, Mikhailava N, Zaikina L, Piirsoo M, Piirsoo A.   +7 more
europepmc   +1 more source